Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Project Publications: University of Washington: Environmental and Genetic Risk Factors for Parkinson's Disease

Superfund Research Program

Environmental and Genetic Risk Factors for Parkinson's Disease

Project Leader: Harvey Checkoway (University of California-San Diego)
Grant Number: P42ES004696
Funding Period: 1995 - 2009
View this project in the NIH Research Portfolio Online Reporting Tools (RePORT)

Project-Specific Links

Connect with the Grant Recipients

Visit the grantee's eNewsletter page Visit the grantee's eNewsletter page Visit the grantee's Facebook page Visit the grantee's Video page

Publications

2007

  • Ton TG, Heckbert SR, Longstreth WT, Rossing MA, KuKull WA, Franklin GM, Swanson PD, Smith-Weller T, Checkoway H. 2007. Calcium channel blockers and beta-blockers in relation to Parkinson's disease. Parkinsonism Relat Disord 13(3):165-9. PMID:17055323

2006

  • Checkoway H. 2006. Methodological challenges in identifying occupational risk factors for neurodegenerative diseases. In: Regional North American Annual Meeting of the World. Federation of Neurology - Research Group on Neuroepidemiology; April 7. San Diego, CA.
  • Kelada SN, Costa-Mallen P, Costa LG, Checkoway H. 2006. 5' and 3' region variation in the dopamine trasporter gene (SLC6A3) and Parkinson's disease risk. In: Regional North American Annual Meeting of the World. Federation of Neurology - Research Group on Neuroepidemiology; April 7. San Diego, CA.
  • Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, Van Den Eeden SK, Gorell J. 2006. Pooled anaylis of tobacco use and Parkinson's disease. Arch Neurol 64(7):990-997. PMID:17620489
  • Ton TG, Heckbert SR, Longstreth WT, Rossing MA, KuKull WA, Franklin GM, Swanson PD, Smith-Weller T, Checkoway H. 2006. Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease. Movement Disorders 21(7):964-969. PMID:16550541

2005

  • Firestone JA, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT, Checkoway H. 2005. Pesticides and risk of Parkinson disease a population-based case-control study. Arch Neurol 62(1):91-95. PMID:15642854
  • Okada S, Farin FM, Stapleton PL, Viernes HA, Quigley SD, Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. 2005. No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes. Neurosci Lett 375(3):178-180. PMID:15694256

2004

  • Costa-Mallen P, Afsharinejad Z, Kelada SN, Costa LG, Franklin GM, Swanson PD, Longstreth WT, Viernes HA, Farin FM, Smith-Weller T, Checkoway H. 2004. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls. Movement Disorders 19(1):76-83. PMID:14743364

2003

  • Costa LG, Cole TB, Jarvik GP, Furlong CE. 2003. Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu Rev Med 54:371-392. doi:10.1146/annurev.med.54.101601.152421 PMID:12525679
  • Kelada SN, Costa-Mallen P, Checkoway H, Costa LG. 2003. Exploration of alternative splicing of monoamine oxidase B transcripts by the intron 13 polymorphism. In: Proceedings of the 42nd Annual Meeting of the Society of Toxicology (SOT), March 9-13, 2003. Salt Lake City, UT.
  • Kelada SN, Costa-Mallen P, Checkoway H, Viernes HA, Farin FM, Costa LG, Longstreth WT, Furlong CE, Jarvik GP, Swanson PD. 2003. Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry 74(4):546-547. PMID:12640090
  • Kelada SN, Stapleton PL, Farin FM, Bammler TK, Eaton DL, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT, Checkoway H. 2003. Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease. Neurosci Lett 337(1):5-8. PMID:12524158
  • Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. 2003. Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 60(11):1761-1766. PMID:12796527

2002

  • Checkoway H, Powers KM, Smith-Weller T, Franklin GM, Longstreth WT, Swanson PD. 2002. Parkinson's disease risks associated with cigarette smoking, alcohol use, and caffeine intake. Am J Epidemiol 155:732-738. PMID:11943691
  • Costa-Mallen P, Kelada SN, Viernes HA, Srinouanprachanh SL, Farin FM, Costa LG, Checkoway H. 2002. DNA sequencing analysis of the monoamine oxidase B gene coding region in Parkinson's disease cases and controls. In: Proceedings of the Tenth International Aamine Oxidases Workshop, August. Istanbul, Turkey.
  • Firestone JA, Franklin GM, Longstreth WT, Smith-Weller T, Swanson PD, Checkoway H. 2002. Occupational exposures to pesticides and risk of Parkinson's disease. In: Proceedings of the World Federation of Neurology Annual Meeting, June. Denver, CO.
  • Firestone JA, Franklin GM, Longstreth WT, Smith-Weller T, Swanson PD, Checkoway H. 2002. Residential pesticide exposures and risk of Parkinson's disease. Presented at the 14th Conference of the International Society for Environmental Epidemiology, Vancouver, BC, August 2002. Epidemiology 13:222Suppl.S.
  • Hernan MA, Checkoway H, O'Brien R, Costa-Mallen P, De Vivo I, Colditz GA, Hunter DJ, Kelsey KT, Ascherio A. 2002. MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD. Neurology 58(9):1381-1387. PMID:12011284
  • Kelada SN, Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT, Checkoway H. 2002. Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease. Neurotoxicology 23(4-5):515-519. PMID:12428723

2001

  • Farin FM, Hitosis Y, Hallagan SE, Kushleika JV, Woods JS, Janssen P, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H. 2001. Genetic polymorphisms of superoxide dismutase in Parkinson's disease. Movement Disorders 16(4):705-707. PMID:11481695
  • Farin FM, Janssen P, Quigley SD, Abbott D, Hassett C, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT, Omiecinski CJ, Checkoway H. 2001. Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease. Pharmacogenet Genomics 11(8):703-708. PMID:11692079

2000

  • Costa-Mallen P, Checkoway H, Fishel M, Cohen AW, Smith-Weller T, Franklin GM, Swanson PD, Costa LG. 2000. The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease. Neurosci Lett 278(1-2):33-36. PMID:10643794
  • Kirchner SC, Hallagan SE, Farin FM, Dilley J, Costa-Mallen P, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H. 2000. Mitochondrial Complex I (ND1 subunit) sequence analysis and association of the T4216C mutation with Parkinson's disease. Neurotoxicology 21:441-446. PMID:11022854

1999

  • Anderson C, Checkoway H, Franklin GM, Beresford S, Smith-Weller T, Swanson PD. 1999. Dietary factors in Parkinson's disease: the role of food groups and specific foods. Movement Disorders 14(1):21-27. PMID:9918340
  • Checkoway H, Nelson LM. 1999. Epidemiologic approaches to the study of Parkinson's disease etiology. Epidemiology 10(3):327-336. PMID:10230846

1998

  • Checkoway H, Farin FM, Costa-Mallen P, Kirchner SC, Costa LG. 1998. Genetic polymorphisms in Parkinson's disease. Neurotoxicology 19:635-643. PMID:9745923
  • Checkoway H, Franklin GM, Costa-Mallen P, Smith-Weller T, Dilley J, Swanson PD, Costa LG. 1998. A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease. Neurology 50(5):1458-1461. PMID:9596006

1997

  • Costa-Mallen P, Checkoway H, Levy D, Smith-Weller T, Franklin GM, Swanson PD, Costa LG. 1997. Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson's Disease. Am J Med Genet 74:154-156. PMID:9129714

1996

  • Kushleika JV, Checkoway H, Woods JS. 1996. Selegiline and lymphocyte superoxide dismutase activities in Parkinson's disease. Ann Neurol 39:278-281. PMID:8602757
  • Kushleika JV, Checkoway H, Woods JS, Moon J, Smith-Weller T, Franklin GM, Swanson PD. 1996. Selegiline (L-Deprenyl) mediates increased lymphocyte cytosolic and mitochondrial superoxide dismutase activities in Parkinson's Disease. Ann Neurol 39(3):378-381.

1995

  • Brodkin CA, Daniell WE, Checkoway H, Echeverria D, Johnson J, Wang K, Sohaey R, Green D, Redlich CA, Gretch D. 1995. Hepatic ultrasonic changes in workers exposed to perchlorethylene. Occup Environ Med 52(10):667-685. PMID:7489059
  • Muller CH, Checkoway H, Alexander BH, Van Netten C, Ewers TG, Faustman EM. 1995. Relationship Between metal exposure and sperm acrosomal function tests among workers at a lead smelter. In: Proceedings of the American Society of Andrology. Raliegh, NC.
  • Muller CH, Checkoway H, Alexander BH, Van Netten C, Ewers TG, Faustman EM. 1995. Sperm function and motility tests among workers at a lead smelter. In: Proceedings of the International Congress of Toxicology - VII. Seattle, WA.
Back
to Top